Nanjing Gaoke Co

Nanjing Gaoke Co EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Nanjing Gaoke Co (600064.SS) as of Nov 4, 2026 is 19.53. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -38.57 — a change of -150.62% (higher).

EV/OCF

19.53

YoY

-150.62%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Nanjing Gaoke Co is 2025 19.53 . EV/OCF (Enterprise Value to Operating Cash Flow) of Nanjing Gaoke Co was 2024 -38.57 . It decreases by -150.62% higher compared to the previous year.

The Nanjing Gaoke Co EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
33.38 CNY
Jan 1, 2019
10.27 CNY
Jan 1, 2020
-6.49 CNY
Jan 1, 2021
29.89 CNY
Jan 1, 2022
-9.24 CNY
Jan 1, 2023
-14.01 CNY
Jan 1, 2024
-38.57 CNY
Jan 1, 2025
19.53 CNY
The Nanjing Gaoke Co EV/OCF history
YEAREV/OCFYoY
19.53-150.62%
-38.57+175.39%
-14.01+51.67%
-9.24-130.90%
29.89-560.51%
-6.49-163.20%
10.27-69.24%
33.38-64.92%
95.16+1,060.51%
8.20-16.76%
9.85-32.79%
14.66—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nanjing Gaoke Co Stock analysis

What does Nanjing Gaoke Co do? Nanjing Gaoke Co., Ltd. generates revenue through its property and municipal business, pharmaceutical operations, and equity investment activities. The company develops residential and commercial properties, manages real estate assets, and provides municipal services in Nanjing, Jiangsu province. Its pharmaceutical business focuses on research, manufacturing, and selling drugs, while equity investments contribute to its income stream. The primary customers for real estate are residents and businesses seeking residential or commercial spaces, and pharmaceutical buyers include healthcare providers and patients in the local market. The company's property and municipal business serves local communities and businesses in Nanjing, Jiangsu, with residential development and property management as key revenue drivers. Pharmaceutical sales target healthcare institutions and end-users within Jiangsu province, leveraging the firm's R&D capabilities. Equity investment activities support diversified income generation without specifying external partners or markets. Nanjing Gaoke's real estate segment includes residential and commercial projects, while its pharmaceutical division handles drug production and distribution. The firm's municipal services integrate with property management to enhance community offerings. Equity investments provide additional financial returns, though specific investment targets are not detailed in the description. Nanjing Gaoke Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanjing Gaoke Co stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Nanjing Gaoke Co is 19.53 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Nanjing Gaoke Co changed from -38.57 to 19.53, representing a -150.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Nanjing Gaoke Co since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Nanjing Gaoke Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Nanjing Gaoke Co

All Key Metrics — Nanjing Gaoke Co